βA1-crystallin regulates glucose metabolism and mitochondrial function in mouse retinal astrocytes by modulating PTP1B activity
- Commun Biol. 2021 Feb 24;4(1):248. doi: 10.1038/s42003-021-01763-5.
- 1. Department of Ophthalmology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
- 2. GROW Research Laboratory, Narayana Nethralaya Foundation, Bengaluru, India.
- 3. Department of Cell Biology and Center for Biologic Imaging, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
- 4. Wilmer Eye Institute, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
- 5. Kodiak Sciences, Palo Alto, CA, USA.
- 6. Institut de la Vision, INSERM, CNRS, Sorbonne Université, Paris, France.
- 7. Department of Pediatrics, Children's Hospital of Pittsburgh, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
- 8. National Eye Institute, National Institutes of Health, Bethesda, MD, USA.
- 9. Department of Ophthalmology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. [email protected].
- 10. Department of Cell Biology and Center for Biologic Imaging, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. [email protected].
- 11. Wilmer Eye Institute, The Johns Hopkins University School of Medicine, Baltimore, MD, USA. [email protected].
- # Contributed equally.
βA3/A1-crystallin, a lens protein that is also expressed in astrocytes, is produced as βA3 and βA1-crystallin isoforms by leaky ribosomal scanning. In a previous human proteome high-throughput array, we found that βA3/A1-crystallin interacts with protein tyrosine Phosphatase 1B (PTP1B), a key regulator of glucose metabolism. This prompted us to explore possible roles of βA3/A1-crystallin in metabolism of retinal astrocytes. We found that βA1-crystallin acts as an uncompetitive inhibitor of PTP1B, but βA3-crystallin does not. Loss of βA1-crystallin in astrocytes triggers metabolic abnormalities and inflammation. In CRISPR/cas9 gene-edited βA1-knockdown (KD) mice, but not in βA3-knockout (KO) mice, the streptozotocin (STZ)-induced diabetic retinopathy (DR)-like phenotype is exacerbated. Here, we have identified βA1-crystallin as a regulator of PTP1B; loss of this regulation may be a new mechanism by which astrocytes contribute to DR. Interestingly, proliferative diabetic retinopathy (PDR) patients showed reduced βA1-crystallin and higher levels of PTP1B in the vitreous humor.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
target: PhosphataseResearch Areas: Endocrinology